DataMEDS AI MEDS 深 滬
等待開盤 09-23 09:30:00 美东时间
4.275
+0.095
+2.27%
華盛通- 最 高5.38
- 今 開4.10
- 成交量 241.34万股
- 最 低 3.91
- 昨 收 4.18
- 總市值 1366.99万
- 52周最高 2228.00
- 市盈率 靜 --
- 換手率 75.48%
- 52周最低 0.8225
- 委 比 -66.67%
- 總股本 319.76万
- 歷史最高 2228.00
- 量 比 0.04
- 振 幅 35.17%
- 歷史最低 0.8225
- 每 手 1
- 風險率 1.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多DataMeds AI Settles Litigation, Strengthens Balance Sheet
DataMeds AI ( ($MEDS) ) has issued an announcement. On September 11, 2026, Data...
09-18 06:02
DataMEDS AI shares are trading higher after Axe Compute announced the sale of its legacy AI cancer diagnostics laboratory business, Helomics, to DataMEDS in an all‑stock transaction.
DataMEDS AI shares are trading higher after Axe Compute announced the sale of its legacy AI cancer diagnostics laboratory business, Helomics, to DataMEDS in an all‑stock transaction.
09-16 00:44
DataMEDS AI reports Q2 results
DataMEDS AI press release (MEDS): Q2 Net loss per share was $7.13 Revenue was $1.779M in Q2 2026, up 14% sequentially from Q1 2026 and above management projections. More on Wellgistics Health Wellgist...
08-19 15:33
DataMEDS AI Q2 EPS $(7.13) Down From $(5.40) YoY, Sales $1.780M Down From $7.791M YoY
DataMEDS AI (NASDAQ:MEDS) reported quarterly losses of $(7.13) per share. This is a 32.04 percent decrease over losses of $(5.40) per share from the same period last year. The company reported $1.780 million in sales this quarter. This is a 77.15 percent decrease over sales of $7.791 million the sam...
08-17 21:05
DataMeds AI Reports Pharmacy Unit Corexa Health July Sales Of $600K+ With Annual Run Rate $7M+; Corexa Completes Registration With TrumpRx To Offer Patients Access To Oral GLP-1 Agonist Drugs
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solu...
08-12 19:44
Wellgistics Health Signs Transformative Strategic Acquisition Agreement
An announcement from Wellgistics Health Inc ( ($WGRX) ) is now available. On Ju...
08-05 05:38
DataMeds AI, Datavault AI Amend Definitive Agreement To Expand PharmacyChain Blockchain-Related Technology Licensing Relationship Beyond Pharmaceutical Distribution
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization ...
07-29 22:17
Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings
Trxade Group (MEDS) has issued an announcement. On July 25, 2024, TRxADE HEALTH...
2024-08-01 05:51
Trxade Health acquires Scienture in all-stock transaction valued at $103M
TRxADE HEALTH (NASDAQ:MEDS) and Scienture has announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction. TRxADE acquired all of Scienture’s assets in exchange f...
2024-07-26 22:47
Trxade Group declares $1.50 special dividend
Trxade Group (NASDAQ:MEDS) declares $1.50/share special dividend. Payable July 24; for shareholders of record July 19; ex-div July 19. See MEDS Dividend Scorecard, Yield Chart, & Dividend Growth. More...
2024-07-09 20:06
